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Abstract
G protein-coupled receptors (GPCRs) constitute the largest family of membrane proteins in the human genome. Their
signaling is regulated by scaffold proteins containing PDZ domains, but although these interactions are important for GPCR
function, they are still poorly understood. We here present a quantitative characterization of the kinetics and affinity of
interactions between GPCRs and one of the best characterized PDZ scaffold proteins, postsynaptic density protein 95 (PSD-
95), using fluorescence polarization (FP) and surface plasmon resonance (SPR). By comparing these in vitro findings with
colocalization of the full-length proteins in cells and with previous studies, we suggest that the range of relevant
interactions might extend to interactions with Ki = 450 mM in the in vitro assays. Within this range, we identify novel PSD-95
interactions with the chemokine receptor CXCR2, the neuropeptide Y receptor Y2, and four of the somatostatin receptors
(SSTRs). The interaction with SSTR1 was further investigated in mouse hippocampal neurons, where we found a clear
colocalization between the endogenously expressed proteins, indicating a potential for further investigation of the role of
this interaction. The approach can easily be transferred to other receptors and scaffold proteins and this could help
accelerate the discovery and quantitative characterization of GPCR–PDZ interactions.
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Introduction
G protein-coupled receptors (GPCRs), also called seven-
transmembrane receptors, constitute the largest family of mem-
brane proteins in the human genome [1]. Their signaling is
mediated by numerous proteins and is still not completely
elucidated. This network of proteins is organized and regulated
by scaffold proteins forming several transient interactions with
GPCRs and cytosolic signaling proteins [2–5]. In this way, scaffold
proteins influence several aspects of GPCR signaling, such as
desensitization, internalization, and post-endocytic sorting; the
understanding of these interactions is therefore important to
understand cell signaling.
PDZ domains are among the most common protein interaction
domains in scaffold proteins: More than 150 human proteins
contain one or more of these 80–100 amino acid (aa) domains,
often in combination with other protein interaction domains [6].
PDZ domains typically form weak transient complexes (i.e.
complexes that readily dissociate) with C-terminal short linear
motifs [7].
The scaffold protein postsynaptic density protein 95 (PSD-95) is
one of the major components of the postsynaptic density of
excitatory glutamatergic synapses, where it organizes signaling
complexes close to the membrane [6]. PSD-95 contains a Src
homology 3 (SH3)–guanylate kinase-like (GK) supramodule and
three PDZ domains that bind to class I PDZ motifs (–X–S/T–X–
W–COO2, where X is any aa, and W is a bulky hydrophobic aa [F,
I, L, M, V, W]). The first two PDZ domains in PSD-95 are
separated by only 5 aa and constitute a supramodule that
generates larger clusters of Kv1.4 channels than a mutant with a
14 aa linker between the two domains [8].
A few GPCRs have been shown to interact specifically with the
PDZ domains of PSD-95 with various effects on GPCR signaling;
for example, PSD-95 was shown to be important for the dendritic
localization of the 5-hydroxytryptamine receptor 2A (5-HTR2A) in
cortical pyramidal neurons [9] and to increase the agonist efficacy
and decrease the agonist mediated internalization of 5-HTR2A in
HEK293 cells [10]. In the case of the b1-adrenergic receptor
(b1AR), PSD-95 was shown to decrease agonist stimulated
internalization of the receptor and to facilitate interaction between
b1AR and the NMDA receptor [11].
Although many GPCR–PDZ interactions are now known, most
have only been described by qualitative methods, such as yeast
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two-hybrid [11], protein arrays [12], pull-down [2], co-immuno-
precipitation [10,13], and affinity purification [13,14]. To predict
how a cell behaves under different conditions, it is necessary to
describe the interactions quantitatively, i.e. in terms of affinity and
kinetics, and to know how a protein interacts with the individual
domains for multidomain proteins, such as scaffold proteins.
Whereas the domain specificity is known qualitatively for some
GPCR–PSD-95 interactions [11,14–16], the affinity and kinetics is
not known for any of them.
Here, we determine the affinity, kinetics and domain preference
for the interactions between PSD-95 and a wide range of GPCRs.
As it is inherently difficult to perform quantitative measurements
and to obtain information about the molecular details of an
interaction in the complex environment of living cells, we have
taken a reductionist approach; we used synthetic peptides
mimicking the C-tails of GPCRs and purified, isolated PDZ
domains from PSD-95 and characterized them in vitro by
fluorescence polarization (FP) and surface plasmon resonance
(SPR). We further show that the affinities measured in vitro are
consistent with colocalization of full-length GPCRs and PSD-95 in
HEK293 cells and in hippocampal neurons.
Results
FP Characterization of GPCR–PDZ Interactions
We measured the in vitro affinity of interactions between a wide
range of GPCR C-terminal tails (C-tails) and the three isolated
PDZ domains composing PSD-95. A library of 34 synthetic
peptides mimicking the C-terminal 10 aa of GPCR C-tails (25 of
them with a class I PDZ motif) was constructed for this purpose
(Table S1). The affinities were measured by FP, which is a
solution-based technique that does not require separation of
bound from unbound ligand. This method has previously proved
suitable for measuring the affinity of PDZ domain interactions
[17–19].
We used a competition set-up, where a constant concentration
of isolated PSD-95 PDZ domain and a labeled reference ligand
was titrated with unlabeled peptides from the GPCR C-tail library,
typically within a 1–512 mM concentration range, and the
resulting curves were fitted to obtain the IC50, which was used
to calculate the Ki (Figure 1). Three Cy5-labeled peptides with
well-documented interactions with PSD-95 were used as reference
ligands for the competition assay: Cy5-KIF1Ba was used for PDZ1
[20], Cy5-GluN2B (formerly known as NR2B) was used for PDZ2
and PDZ1-2 [21], and Cy5-CRIPT was used for PDZ3 [22]
(Table S1). Competition with unlabeled versions of the reference
ligands was used to validate the FP assay by comparison with the
literature (Table S2).
We determined the Ki for 7 uncharacterized known binders and
8 potential new binders (Table 1) and identified 19 non-binders
(Table S3). Most of the receptors that had previously been shown
to interact with PSD-95 in cells or tissues were found among the
strongest interactions (considering only the interaction with the
strongest binding PDZ domain for each GPCR C-tail); specifically,
5-HTR2A, 5-HTR2C, b1AR, and BAI1 receptor interacted with
PDZ2 with Ki around 100 mM or lower. One of the previously
untested peptides, human SSTR1 (hSSTR1), interacted with
PDZ2 with a Ki below 100 mM, making it a good candidate for
studies in cells.
Most of the newly identified interactions had Ki in the 200–
450 mM range, specifically the chemokine receptor CXCR2, the
neuropeptide Y receptor Y2, SSTR2A, SSTR3, and hSSTR4,
whereas only one of the interactions identified in the literature,
mSSTR4, was found in this range. It is thus not clear from the
current literature whether these receptors are likely to interact with
PSD-95 in cells.
Kinetics of GPCR–PDZ Interactions
To confirm the affinities measured by FP using an orthogonal
method and to get information about the kinetics of the GPCR–
PDZ interactions, we used SPR. This label-free, surface sensitive
technique measures the binding of a ligand to an immobilized
protein as a function of time based on refractive index changes. In
order to characterize the interactions between PSD-95 and GPCR
C-tails, we immobilized the three PSD-95 PDZ domains on
separate carboxymethyl dextran surfaces and confirmed the
function of the immobilized PDZ domains with the same reference
ligands as in the FP assay (Table S4): KIF1Ba for PDZ1 [20],
KIF1Ba and GluN2B for PDZ2 [20,21], and CRIPT for PDZ3
[22].
For each of the PSD-95 PDZ domains, we determined the Kd
and the stability of the complexes for selected GPCR C-tail
peptides. The residence time t ( = 1/kd) was used as a convenient
measure of the stability of the complexes [23]. For all three PDZ
domains, we observed a clear interaction with the well-character-
ized binder 5-HTR2C, whereas a receptor without a PDZ motif,
the ghrelin receptor (RAWTESSINT–COO–), did not interact
(Figure 2A). The Kd determined from the steady-state responses of
a range of C-tail peptide concentrations (Figure 2B and Table S4)
correlated well with the Ki values obtained by FP (Figure S1).
For all combinations of PDZ domains and GPCR C-tail
peptides, we observed dissociation of the complexes within the first
second of the dissociation phase (Figure 2A) (faster than the time-
resolution of the instrument), meaning that t is less than 1 s (kd
.1 s21). This implies that the GPCR–PDZ complexes are very
transient, which is in agreement with previous work [24].
Domain Preference and Peptide Selectivity
The Ki values obtained for each of the PSD-95 PDZ domains
facilitate analysis of the PDZ domain preference of the receptors
and the peptide-binding selectivity of the PDZ domains. We
compared the binding to the different PDZ domains pairwise
using scatter plots of the Ki for binding of the C-tail peptides to
each of the two domains. If the C-tails bound to the domains with
the same affinity, the points should be distributed around a line
with a slope of 1 (the dashed line in Figure 3A–D). Comparison of
the binding to PDZ1 and PDZ2 showed that most C-tail peptides
bound preferentially to PDZ2 (Figure 3A). Three receptors (the
metabotropic glutamate receptors mGlu1(a) and mGlu7(a) receptors
and SSTR3) deviated from this trend by binding to PDZ1, but not
to PDZ2; all three receptors were weaker binding receptors with Ki
above 600 mM. Further analysis of the PDZ1/PDZ2 scatter plot
showed that the points were distributed around a line that was
parallel to the dashed line, but shifted 1.7–3.2 times (95%
confidence interval) along the x-axis. This suggests that the
peptide-binding selectivity of PDZ1 and PDZ2 is the same, but the
Ki for binding to PDZ2 is 1.7–3.2 times lower than for binding to
PDZ1.
Comparison of PDZ3 with PDZ1 and PDZ2 showed that most
C-tail peptides bound preferentially to PDZ1 and PDZ2 over
PDZ3, but, in contrast to the PDZ1/PDZ2 scatter plot, there was
no trend in the distribution of the points (Figure 3B–C). The only
PDZ3 selective C-tail, besides the reference peptide CRIPT, was
SSTR3. This shows that the peptide-binding selectivity of PDZ3 is
different from the selectivity of PDZ1 and PDZ2 and that PDZ3
selective receptors are less abundant than PDZ1 and PDZ2
selective receptors in our C-tail peptide library.
PSD-95 Interactions with GPCRs
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PDZ1-2 Supramodule
The first two PDZ domains of PSD-95 constitute a supramo-
dule, PDZ1-2, which has been hypothesized to have binding
properties that are different from those of the isolated domains [8].
Using the same approach as for the isolated domains, we
compared the Ki for binding of C-tail peptides to the PDZ2 part
of the PDZ1-2 supramodule (PDZ2*) with binding to isolated
PDZ2 under the assumption that the PDZ2 selective probe Cy5-
GluN2B is also selective for PDZ2*. Comparison of binding to
isolated PDZ2 and binding to PDZ2* showed that the points were
all positioned close to the dashed line (Figure 3D), indicating that
the binding characteristics of isolated PDZ2 and PDZ2* were
similar. Closer analysis showed that the Ki for binding to PDZ2*
was 1.04–1.32 (95% confidence interval) times higher than the Ki
for binding to isolated PDZ2. Although significant, this minor
difference should not change the conclusions obtained with the
isolated PDZ2 domain. In conclusion, the peptide-binding
selectivity is the same for isolated PDZ2 and PDZ2* and the
affinity is similar, which is consistent with a previous study of the
GluN2B C-tail binding to PDZ2* [25].
Figure 1. Representative FP competition curves. Binding of 1–512 mM GPCR C-tail peptides to a fixed concentration of PSD-95 PDZ1 (left
panel), PDZ2 (middle panel) or PDZ3 (right panel) and Cy5-labeled probe. The data points are averages of three independent measurements, and the
error bars represent the standard error of the mean. The solid lines are the fitted curves.
doi:10.1371/journal.pone.0063352.g001
Table 1. Ki values for GPCR C-tail interactions with the PSD-95 PDZ domains determined by FP.
Ki (mM)a,b
Competitor Species Family PDZ1 PDZ2 PDZ3
Previously
known
5-HTR2A Human 5-Hydroxytryptamine receptors 16064 4660.2
c NA [9,10]
5-HTR2C Human 5-Hydroxytryptamine receptors 10060.1
c 2660.4c 370640 [13,15]
b1AR Human Adrenergic receptors 430647 120620
c 360682c [11]
b2AR Human Adrenergic receptors NA 720615
c NA [16]
CXCR2 Human Chemokine receptors 280625c 370653 370639
BAI1 Human Class B Orphans 6366.3c 2961.9c 790693 [18]
mGlu1(a) Human Metabotropic glutamate receptors 830682 NA NA
mGlu7(a) Human Metabotropic glutamate receptors 610651 NA NA
Y2 Human Neuropeptide Y receptors 270622 230614
c NA
SSTR1 Human Somatostatin receptors 5063.2c 2862c 200634
SSTR1 Mouse Somatostatin receptors 270635 90614c NA [14]d
SSTR2A Human Somatostatin receptors 6206106 23062c NA
SSTR3 Human Somatostatin receptors 6106125 NA 28065c
SSTR4 Human Somatostatin receptors 750680 450658 600667
SSTR4 Mouse Somatostatin receptors NA 420652 NA [14]
aThe shown data are Ki 6 fitting error, unless otherwise noted.
bNA, no affinity, defined as a Ki value above 1000 mM.
cShown data are mean Ki 6 standard error of the mean from two or more independent experiments.
dOnly shown to interact with PSD-95 in vitro.
doi:10.1371/journal.pone.0063352.t001
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Colocalization of Proteins in Cells
We used confocal fluorescence microscopy to study the
colocalization and potential for mutual regulation of full-length
GPCRs and PSD-95 in a complex cellular environment, and
compare to the in vitro observations.
Cells were cotransfected with plasmids encoding GFP-tagged
PSD-95 (PSD-95-GFP) and GPCRs fused to SNAP-tag (SNAP-
GPCR) [26]. The receptors on the cell surface were fluorescently
labeled by an irreversible reaction between the SNAP-tag and the
cell-impermeable substrate BG-647, thus eliminating the back-
ground signal from intracellular receptor populations. We used
line scans across the membrane to evaluate the distribution of
PSD-95-GFP and SNAP-GPCRs near the plasma membrane.
As a reference, the distribution of PSD-95-GFP in the absence
of overexpressed GPCR was analyzed in cells labeled with the
membrane dye DiD. Under those conditions, PSD-95-GFP was
distributed evenly in the cytosol, as illustrated on the confocal
micrographs and in the line profiles (Figure 4A). When cells
coexpressed SNAP-5-HTR2C or SNAP-b1AR and PSD-95-GFP,
PSD-95-GFP was partly redistributed to the cell membrane
(Figure 4B–C). The line profiles show that the PSD-95-GFP signal
peaks at the membrane and then decreases steeply to a constant
lower level in the cytosol (Figure 4B–C, right panel).
In contrast, the PSD-95-GFP distribution in cells coexpressing a
receptor without PDZ motif, SNAP-k opioid receptor (kOR,
RDIDGMNKPV–COO–), or a receptor where the PDZ motif is
disrupted by adding three alanines to the C-terminus of the
receptor, SNAP-b1AR-AAA, was similar to the distribution in cells
without overexpressed receptor (Figure 4D–E). This indicates that
the observed redistributions indeed result from specific PDZ
interactions. These results are consistent with the in vitro results,
showing PSD-95 interactions with 5-HTR2C and b1AR and no
interaction with kOR, and with the literature [11,13,15].
We then looked at the strongest binder among the identified
in vitro interactions, hSSTR1: Coexpression of PSD-95-GFP and
SNAP-hSSTR1 resulted in a distribution pattern similar to the
distribution in cells cotransfected with SNAP-5-HTR2C
(Figure 5A). Moreover, when the hSSTR1 PDZ motif was
disrupted by adding three alanines to the C-terminus of the
receptor (SNAP-hSSTR1-AAA), no redistribution of PSD-95-GFP
was observed (Figure 5B). Together, these results indicate that the
colocalization of hSSTR1 and PSD-95 is governed by a specific,
PDZ domain-mediated interaction.
Similarly, we observed redistribution of PSD-95-GFP to the
membrane upon coexpression with SNAP-Y2 or SNAP-CXCR2
(Figure 5C–D), indicating that these receptors associated with
PSD-95 in cells. As for the interaction with mSSTR4 identified in
the literature, we measured the in vitro Ki values by FP for the
interactions between the PSD-95 PDZ domains and CXCR2 and
the Y2 receptor to be in the 200–450 mM range (the observed Kd
Figure 2. Time-resolved binding of GPCR C-tails to the PSD-95 PDZ domains. Binding of GPCR C-tail peptides to immobilized PSD-95 PDZ1
(left panel), PDZ2 (middle panel), or PDZ3 (right panel) monitored by SPR. (A) Time-resolved binding of 500 mM GPCR C-tail peptides. (B) Steady-state
responses and the corresponding fitted curves (solid lines). The curves are reference and blank subtracted.
doi:10.1371/journal.pone.0063352.g002
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in cells is most likely much lower, which is discussed in detail later).
These interactions are weaker in vitro than most of the interactions
identified in the literature, suggesting that there is a potential for
discovery of many new GPCR–PDZ interactions within this range.
The interaction between b2AR and PSD-95 was among the
weakest we quantified by FP (Ki = 720 mM). Consistent with this,
we could not detect a redistribution of PSD-95-GFP upon
coexpression with SNAP-b2AR (Figure 5E). This interaction is
thus possibly too weak to be detected by our approach.
The colocalization between PSD-95 and the GPCRs tested here
is in excellent agreement with our in vitro results. Furthermore, we
show that the colocalizations between PSD-95 and hSSTR1 and
b1AR are mediated by a PDZ motif. This indicates that the
colocalizations are in fact mediated by direct interactions between
the PDZ domains of PSD-95 and the GPCR C-tails. It should,
however, be kept in mind that our assay is not able to distinguish
the presence of additional proteins involved in the interaction
between PSD-95 and the GPCR C-tail in a cellular environment.
Endogenous mSSTR1 Colocalizes with PSD-95 in Primary
Neurons
To test whether endogenous mSSTR1 and PSD-95 are
naturally expressed in the same cells and colocalize at physiolocal
concentrations of the proteins, we analyzed the cellular localiza-
tion of endogenous mSSTR1 and PSD-95 in cultured primary
murine hippocampal neurons using immunocytochemistry with
antibodies interacting specifically with mSSTR1 (Figure 6) and
PSD-95 [27] (Figure S2). mSSTR1 was in many neurons detected
Figure 3. Domain preference and peptide selectivity. Comparison of Ki values for binding of GPCR and reference (KIF1Ba, GluN2B, and CRIPT)
C-tail peptides to PSD-95 PDZ2 and PDZ1 (A), PDZ2 and PDZ3 (B), PDZ1 and PDZ3 (C), and isolated PDZ2 and PDZ2 in the PDZ1-2 supramodule (D).
The dashed lines represent identical Ki values for the two domains. The dotted lines in A and D are line fits to the data points; C-tails binding to only
one of the domains were omitted from the fitting. NA, no affinity, defined as a Ki value above 1000 mM. Error bars represent fitting errors or the
standard error of the mean (see Table 1).
doi:10.1371/journal.pone.0063352.g003
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in dendrites and at the soma in fluorescent clusters. Costaining
with anti-PSD-95 clearly indicated a colocalization of both
proteins, most likely at postsynaptic sites on dendritic spines
(Figure 6). These data indicate that neuronal mSSTR1 is spatially
Figure 4. Validation of colocalization assay. PSD-95 is visualized by fusion to GFP, the receptors by fusion to SNAP-tag and labeling with the
fluorescent SNAP-tag substrate BG-647. Cells transfected only with PSD-95-GFP were stained with DiD to visualize the plasma membrane. (A) Cells
transfected with PSD-95-GFP only. (B–F) Cells coexpressing PSD-95-GFP and SNAP-5-HTR2C (B), SNAP-b1AR (C), SNAP-kOR (D), or SNAP-b1AR-AAA (E).
The graphs (right) show averaged line scans along the regions of interest indicated on the overlay images. The signal from SNAP-GPCRs and the
membrane dye is shown in red; PSD-95-GFP is shown in green. Scale bars are 10 mm.
doi:10.1371/journal.pone.0063352.g004
PSD-95 Interactions with GPCRs
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associated with PSD-95 in cultured neurons, which is a
prerequisite for physical interaction and thus supports further
investigation of the physiological relevance of the identified
mSSTR1–PSD-95 interaction.
Figure 5. GPCR–PSD-95 interactions identified by FP colocalize in cells. PSD-95 is visualized by fusion to GFP, the receptors by fusion to
SNAP-tag and labeling with BG-647. Cells coexpressing PSD-95-GFP and SNAP-hSSTR1 (A), SNAP-hSSTR1-AAA (B), SNAP-Y2 (C), SNAP-CXCR2 (D), or
SNAP-b2AR (E). The graphs (right) show averaged line scans along the regions of interest indicated on the overlay images. The signal from SNAP-
GPCRs is shown in red; PSD-95-GFP is shown in green. Scale bars are 10 mm.
doi:10.1371/journal.pone.0063352.g005
PSD-95 Interactions with GPCRs
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Discussion
We here present the first quantitative characterization of the
kinetics and affinity of interactions between GPCRs and one of the
best characterized PDZ scaffold proteins, PSD-95, using a generic
approach that is straightforward to expand to other scaffold
proteins. We determined the Kd of interactions between peptides
mimicking GPCR C-tails and the isolated PDZ domains of PSD-
95 by FP. The Kd values were confirmed by SPR and we could
furthermore estimate the upper limit for the residence time of
GPCR–PSD-95 interactions. These in vitro findings were consis-
tent with the co-localization of full-length GPCRs and PSD-95 in
HEK293 cells and finally, we found that SSTR1 colocalized with
PSD-95 in mouse hippocampal neurons.
Predicting GPCR–PDZ Association in Cells Based on
in vitro Affinities
We measured the affinity of the PSD-95 PDZ domains for 15
GPCR C-tails. Even though we find a good qualitative correlation
between in vitro and cell data, the in vitro affinities are not likely to
correspond to the apparent affinities in cells. They are, however,
still very useful and can be used to determine which interactions
are most likely to occur in a cellular environment, as we have
shown here. Moreover, GPCRs can be ranked on the basis of their
affinities, which can be used to predict the outcome if several
receptors interacting with the same PDZ domain are expressed in
the same cell.
Apparent affinities in cells might differ from in vitro affinities for
a number of reasons: First, PSD-95 has several interaction
domains and is thus capable of binding more than one membrane
embedded receptor at the same time, which can increase the
apparent affinity, or avidity, by several orders of magnitude [19];
indeed, forming several weak transient interactions is a common
feature of scaffold proteins [28]. Most of the receptors that interact
with PSD-95 have a significant affinity for at least two of the PDZ
domains and in some cases, e.g. Y2 and CXCR2, the affinity for
two or three domains is practically identical, making this scenario
very likely to occur. Second, PSD-95 is palmitoylated, which most
likely positions it at the cell membrane in close proximity to the
receptors, thus increasing the association rate [29]. Third, the
environment in the cell is different from typical in vitro conditions:
The presence of the plasma membrane, macromolecular crowd-
ing, and different electrolyte concentrations can influence the
interaction. In fact, a high chloride concentration has been shown
to decrease the affinity of PDZ motif peptides binding to PSD-95
PDZ2 and PDZ3 [24,30,31]. Fourth, the affinity can be
modulated either allosterically by interaction with another protein
or by posttranslational modification of either the GPCR or PSD-
95.
Based on the simplified assumption that the Ki for the strongest
in vitro interaction with the PSD-95 PDZ domains is proportional
to the strength of the interaction between the full-length proteins
in cells, the GPCRs were divided into three groups: Group 1: Ki
around 100 mM or less, approximately corresponding to the cut-
off used in a large scale screening of PDZ interactions by a
combination of protein microarray and FP [17], Group 2: Ki in the
range 200–450 mM, and Group 3: Ki higher than 450 mM. Most
of the PSD-95 interacting receptors identified in the literature
belonged to Group 1 (5-HTR2A, 5-HTR2C, b1AR, BAI1 receptor,
mSSTR1 (Table 1)). Interestingly, we found that the Group 2
receptors CXCR2 and the Y2 receptor colocalized with full-length
PSD-95 in cells. Furthermore, Group 2 contains SSTR4, which
has previously been shown to co-immunoprecipitate with PSD-95
from rat brain (the C-tail of rat and mouse SSTR4 is identical)
[14] and together, these results indicate that receptors in Group 2
are good candidates for physiologically relevant interactions. This
is a significant expansion of the range of interactions that is usually
investigated further, which could lead to the discovery of many
new GPCR–PDZ interactions. Indeed, the physiologically relevant
interaction between the cystic fibrosis transmembrane conduc-
tance regulator (CFTR) and the PDZ domain of the CFTR-
associated ligand (CAL) has been shown to have a Kd above
600 mM in vitro [32].
Kinetics of PDZ Domain Interactions: Implications for
Screening Assays
We measured the binding of at least 5 GPCR C-tail peptides to
each of the PSD-95 PDZ domains by time resolved SPR and
Figure 6. mSSTR1 and PSD-95 colocalize in primary hippocampal neurons. Mouse neurons cultivated for 20 days in vitro were stained for
mSSTR1 (red signal) and PSD-95 (green signal). Yellow color in the merged picture (right panels) indicates colocalization of mSSTR1 and PSD-95 and is
particularly seen on dendritic spines. The lower panels show a magnification of the dashed region depicted in the overviews. Nuclei of primary
neurons were counterstained with DAPI (left panels). Several neurons were not stained by the anti-SSTR1 antibody (indicated by arrowheads),
indicating that the mSSTR1 staining is specific. Scale bars are 10 mm.
doi:10.1371/journal.pone.0063352.g006
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found that all of the C-tails dissociated with residence times below
one second (t,1 s). This is in agreement with values of t=0.014–
0.22 s (kd = 4.6–72 s
21) reported for stopped-flow fluorimetry
measurements of PDZ domain interactions with known (non-
GPCR) ligands [24]. The transient nature of GPCR–PDZ
interactions is consistent with a role in organization of signaling
complexes: it allows quick formation and dissociation of individual
PDZ interactions in response to cellular events, while the modular
design of PDZ scaffolds imparts a residence time of the full-length
protein that is much longer than for the isolated domains and this
stability is important for the function of PDZ scaffolds as
organizational hubs.
Kinetics of PDZ domain interactions is also interesting from a
methodological perspective, because most of the assays used to
discover and characterize PDZ domain interactions require
physical separation of the bound and free fractions, which is often
done by immobilization on a solid support followed by a series of
washing steps. Examples of such assays include affinity purification
[13,14], co-immunoprecipitation [10,13], pull-down [2], and
protein arrays [12,33]. In those cases, the separation step can
influence the outcome of the assay if a substantial fraction of
complexes dissociate during the separation, which is often the case
for transient interactions. This leads to underestimation of the
affinity and a higher probability of false negatives and is most likely
the reason why so few of the Group 2 interactions that we report
here were discovered previously, whereas only one of the Group 1
interactions was new. Consequently, it is important to use
separation independent methods, such as FRET, FP, and SPR,
to characterize PDZ domain interactions.
Interactions Identified or Confirmed
Two different isoforms of SSTR1 were used in this study: We
showed by FP and SPR that human SSTR1 interacts with PSD-95
and showed colocalization of the proteins in HEK293 cells by
confocal fluorescence microscopy. For mouse SSTR1, we showed
by FP that it also interacts with PSD-95 in vitro, thus confirming a
previous study [14] and in good agreement with a study on the
interaction between mSSTR1 and a PSD-95 homolog, synapse-
associated protein 97 [34]. We further demonstrated that
mSSTR1 is coexpressed with PSD-95 in hippocampal neurons
and is colocalized with PSD-95 at dendritic spines, which has not
previously been demonstrated. Finally, the FP assay showed that
both isoforms interact preferentially with the same domains of
PSD-95, but the interaction with hSSTR1 was significantly
stronger (P = 0.047, two-tailed, unpaired Student’s t test), probably
due to slight differences in the 22 and the 26 positions of the two
C-tail sequences (using the numbering scheme of Doyle et al. [35]).
The clear colocalization of PSD-95 and the weaker binding mouse
isoform of SSTR1 in hippocampal neurons suggests that hSSTR1
is also found in a complex with PSD-95 at physiological
concentrations and in their native environment.
Besides SSTR1, we identified interactions of CXCR2 and the
Y2 receptor with PSD-95 in vitro and observed colocalization of the
proteins in HEK293 cells. Furthermore, we identified PSD-95
interactions with SSTR2A, SSTR3, hSSTR4, the mGlu1(a)
receptor, and the mGlu7(a) receptor in vitro.
The interaction between b2AR and PSD-95 has been subject of
some controversy: Joiner et al. have shown that the complete C-tail
of b2AR binds PSD-95 PDZ3 in vitro, and that b2AR co-
immunoprecipitates with PSD-95 from rat brain extract [16].
However, Hu et al. reported that b2AR does not interact with
PSD-95 in vitro or in HEK293 cells [11]. In our hands, the
interaction was close to the detection limit in the in vitro assays and
we could not detect association in cells. Our results are thus most
consistent with the results from Hu et al.
Peptide-binding Selectivity
We found that the peptide-binding selectivity of PDZ1 and
PDZ2 was similar, but PDZ2 generally bound peptides with
higher affinity than PDZ1. This tendency was previously observed
with the C-tail from nine different proteins in a general screening
[17] and seen consistently during systematic investigations of the
GluN2B C-tail [18,36]. Two residues that participate in the
stabilization of the C-terminal carboxylate group in the ligand are
different in PDZ1 and PDZ2, namely Arg-70 and Gly-141 in
PDZ1, which are Lys-165 and Tyr-236, respectively, in PDZ2
(Figure S3). These differences might explain why PDZ2 binds
ligands with higher affinity than PDZ1, but the same selectivity.
PDZ3 showed a different peptide-binding selectivity than PDZ1
and PDZ2, but only few PDZ3 selective ligands were found. The
difference in selectivity is probably partly due to differences in a
number of the residues that contact the ligand side chains, for
example residues 2 and 4 in b-strand bB and residues 4 and 5 in
bC, and partly due to a 6 residue insert in the bB/bC loop (Figure
S3). The lack of PDZ3 selective ligands has also been observed in
screenings of broader ranges of natural ligands [17,37], but a
screening of artificial ligands showed that PDZ3 is as promiscuous
as PDZ2 [37], thus suggesting that PDZ3 selective ligands are
simply underrepresented in the genome.
Conclusions
We have analyzed the interactions between a prototypical PDZ
scaffold protein, PSD-95, and a wide range of GPCRs in vitro and
in cells. We found by SPR that GPCR–PSD-95 PDZ interactions
are transient (t ,1 s), which is consistent with a role in dynamic
signaling events.
In vitro results obtained with FP and SPR showed that most of
the GPCR–PSD-95 interactions identified in the literature have Ki
values around 100 mM or lower (Group 1). The interaction
between PSD-95 and SSTR1 was also in this range and we
furthermore demonstrated that the endogenous full-length pro-
teins colocalize in mouse hippocampal neurons. This shows that a
curated, quantitative data set is useful for predicting which
proteins that are likely to be associated in their native environ-
ment.
We discovered several new GPCR–PSD-95 interactions with
in vitro Ki in the 200–450 mM range (Group 2), including CXCR2,
the Y2 receptor, SSTR2A, SSTR3 and hSSTR4. Measurements
in HEK293 cells showed that full-length CXCR2 and Y2 receptor
also colocalize with PSD-95, suggesting that interactions in this
range could be of physiological relevance. This could lead to the
discovery of many new GPCR–PDZ interactions, as this affinity
range has often been disregarded.
Our approach can easily be applied to other PDZ scaffolds with
minimal changes in the experimental setup and even to other
protein interaction domains, if the appropriate peptide library is
established.
Materials and Methods
Expression and Purification of PSD-95 Constructs
Expression plasmids of PSD-95 PDZ1 (aa 61–151), PDZ2 (aa
155–249), PDZ3 (aa 309–401), and PDZ1-2 (aa 61–249) were
constructed as described previously [36]. All PDZ constructs
contained an additional N-terminal MHHHHHPRGS sequence
for use in His-tag purification.
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Chemically competent E. coli One Shot BL21 Star (DE3)
bacteria were transformed with PDZ expressing plasmids. Protein
expression was induced by addition of 0.5 mM isopropyl b-D-1-
thiogalactopyranoside to bacterial culture at OD600 = 0.8–1.0,
followed by 4 h growth at 37uC (PDZ1, PDZ2, or PDZ3), or at
OD600 = 0.4–0.5, followed by overnight growth at 30uC (PDZ1-2).
Proteins were purified by immobilized metal ion affinity
chromatography followed by size exclusion chromatography on
an A¨KTApurifier 10 (GE Healthcare). Cell pellets with expressed
protein were resuspended in buffer containing 4 mM sodium
phosphate pH 7.4, 0.1 M NaCl, 20 mM imidazole, 1 mg/ml
lysozyme, 1 mM PMSF, and EDTA-free Complete protease
inhibitor cocktail (Roche) and incubated on ice for 30 min. While
still on ice, the bacteria were lysed using a microtip sonicator in six
cycles of 10 s high intensity bursts with 10 s pauses between bursts.
Cell debris was pelleted by centrifugation at 480006g for 45 min
at 4uC followed by addition of 40 mg/ml DNase I and 10 mM
MgCl2 to the lysate. After 15 min incubation on ice, the solution
was cleared by centrifugation (480006g, 10 min, 4uC) and
filtration (0.45 mm filter) and finally diluted 3–4 times in Buffer
A (20 mM sodium phosphate pH 7.4, 0.5 M NaCl) with 20 mM
imidazole and loaded on a HisTrap HP 5 ml column (GE
Healthcare) equilibrated in Buffer A with 20 mM imidazole. Each
PDZ protein was eluted with Buffer A with 250 mM imidazole,
and fractions containing protein were pooled, concentrated with
Amicon Ultra-15 MWCO 3000 (PDZ1, -2, -3) or 10000 (PDZ1-2)
centrifugal filter devices and further purified on a Superdex 75 10/
300 GL column equilibrated in a buffer containing 10 mM
HEPES pH 7.4 and 150 mM NaCl. Again, protein containing
fractions were pooled and concentrated with Amicon centrifugal
filter devices and finally frozen in liquid nitrogen and stored at
280uC. Size and purity (.95%) of the proteins were checked by
SDS-PAGE stained with SimplyBlue SafeStain (Invitrogen).
Protein concentrations were determined from the absorbance at
280 nm, using molar extinction coefficients determined by amino
acid analysis (Alphalyse, Odense, Denmark).
Synthesis of C-tail Peptides
Cy5-labeled NMDA receptor GluN2B subunit, CRIPT, and
KIF1Ba peptides and unlabeled GluN2B and CRIPT peptides
were synthesized and labeled as previously described [36]. The
remaining peptides were synthesized by Schafer-N (Copenhagen,
Denmark). Unlabeled KIF1Ba peptide and the GPCR peptides
corresponded to the 10 C-terminal aa of the proteins with an N-
terminal YDDR/DDR linker to increase solubility and enable
spectrophotometrical determination of the concentration (Tyr was
omitted for peptides already containing Tyr or Trp). Concentra-
tions of unlabeled peptides were determined from the absorbance
at 280 or 293 nm by diluting the peptide stock in 0.1 M NaOH,
and the concentrations of Cy5-labeled peptides were determined
from the absorbance at 650 nm.
Fluorescence Polarization Assay
FP measurements were performed in black, flat bottom 384-well
NBS microplates (Corning) on a Synergy H4 microplatereader
(BioTek Instruments) equipped with a 620/40 nm excitation filter,
a 680/30 nm emission filter, and a 660 nm dichroic mirror.
Polarization values were corrected with blank samples and samples
with fluorescent probe alone. At least 10 data points were
measured for each curve, and each data point was measured in
triplicate. 25 nM Cy5-labeled probe was used for each assay: Cy5-
KIF1Ba for PDZ1, Cy5-GluN2B for PDZ2 and PDZ1-2, and
Cy5-CRIPT for PDZ3. All FP measurements were performed in a
buffer containing 10 mM HEPES pH 7.4, 150 mM NaCl, and
1% BSA and incubated at least 15 min at room temperature
before reading. The signal was stable for more than an hour,
showing that the reaction was at equilibrium.
Saturation binding curves were used to determine the
functionality of the PDZ domains by comparison with literature
values and to calculate Ki values from competition curves.
Saturation binding curves were performed by mixing probe with
a twofold dilution series of PDZ protein in a total volume of 30 ml.
The Kd was determined by fitting to a 1:1 binding model: Y=Ymax
6X/(X+Kd).
For the competition binding curves, probe was mixed with a
constant concentration of PDZ protein corresponding to the Kd
and a twofold dilution series of unlabeled peptide in a total volume
of 30 ml. The baseline was determined using a sample containing
only probe. The IC50 was determined by fitting to a 1:1 binding
model: Y=Ymax 2 Ymax 6X/(X+IC50). The Ki was calculated
from the IC50 and from the Kd for the interaction between the
PDZ protein and the probe as described previously [38].
Surface Plasmon Resonance Assay
A Biacore X100 (GE Healthcare) SPR instrument equilibrated
to 25.0uC and equipped with a Sensor Chip CM5 (for PDZ1 and
PDZ2) or CM4 (for PDZ3) (GE Healthcare) was used for the SPR
measurements. The running buffer was HBS-EP+ (10 mM
HEPES pH 7.4, 150 mM NaCl, 3 mM EDTA, 0.05% Surfactant
P-20 (GE Healthcare)).
PDZ domains were immobilized by amine coupling at a flow
rate of 5 ml/min on a surface activated by a 7 min injection of a
1:1 mixture of 0.4 M 1-ethyl-3-(3-dimethylaminopropyl) carbodii-
mide (EDC) and 0.1 M N-hydroxysuccinimide (NHS). The
remaining active groups were deactivated by a 7 min injection
of 1 M ethanolamine HCl pH 8.5. 750 RU PDZ1, 780 RU
PDZ2, and 410 RU PDZ3 were immobilized.
GPCR C-tail peptide samples were injected in increasing
concentrations for 1 min with 1 min dissociation time at 30 ml/
min. Reproducibility was tested by injecting the 20 mM sample
again after the highest concentration sample. The binding curves
were corrected by subtraction of buffer blanks and the response
from a reference surface that was activated with EDC and NHS
and deactivated with ethanolamine like the surface with immo-
bilized PDZ domain. For peptides with a cysteine, 1 mM
dithiothreitol (DTT) was added to the samples. Steady-state
response curves were plotted from the responses 10 s before
injection end. The Kd was determined by fitting steady-state
response curves to a 1:1 binding model with a linear component to
corrrect for low affinity binding, probably resulting from the
immobilization: Y=Ymax6X/(X+Kd)+B6X.
Ki scatter plots were fitted by linear models after log-
transforming the data. If the fitted slope was close to unity (within
the standard deviation), it was fixed to 1. 95% confidence intervals
were calculated from the fitting errors.
Colocalization in HEK293 Cells
HEK293 cells were cultured at 37uC in DMEM supplemented
with 2.2% FBS, in a 5% CO2 atmosphere with 95% humidity.
Cells were plated on sterile glass cover slips two days before an
experiment. Following overnight incubation, adherent cells were
transiently transfected with the appropriate plasmids in a 1:1 ratio,
using TurboFect (Fermentas) as transfection reagent, according to
the protocol from the manufacturer. Finally, cells were cultured
overnight for protein expression.
PSD-95-GFP was kindly provided by Philippe Marin (Institut de
Ge´nomique Fonctionnelle, Montpellier, France) [39]. Plasmids for
SNAP-tagged receptors (5-HTR2C, b1AR, b2AR, kOR, and
PSD-95 Interactions with GPCRs
PLOS ONE | www.plosone.org 10 May 2013 | Volume 8 | Issue 5 | e63352
hSSTR1) were obtained from Cisbio (France). For SNAP-
hSSTR1-AAA and SNAP-b1AR-AAA, three alanine residues
were added to the C-terminus of the respective wild type plasmids
(GenScript, Piscataway, NJ, USA).
SNAP-GPCR constructs were fluorescently labeled with fluo-
rescent O6-benzylguanine (BG)-647 (New England Biolabs),
according to the protocol from the manufacturer. In short, cells
were incubated for 10 min with 5 mM BG-647 at 37uC and then
washed. In samples that were not transfected with a receptor, cell
membranes were stained with Vybrant DiD cell-labeling solution
(Invitrogen). Subsequently, the cells were imaged in serum-free
DMEM with HEPES (Invitrogen).
Cross section micrographs of cells were acquired on an inverted
confocal microscope (TCS SP5, Leica), using a water immersion
objective (63x magnification, numerical aperture 1.2). GFP was
excited with a wavelength of 488 nm; BG-647 and DiD were
excited with a wavelength of 633 nm.
Images were digitally processed with ImageJ [40] to quantify the
recruitment of PSD-95-GFP to the membrane and the colocaliza-
tion with GPCRs. Straight line regions of interest perpendicular to
the plasma membrane and covering several micrometers inside
and outside the cell were selected manually, and the fluorescence
intensities along these line segments were measured for both the
receptor and PSD-95-GFP. These signals were further treated
using Igor Pro (WaveMetrics). In brief, the position of the
membrane was determined from the receptor fluorescence and set
to 0 mm. At least five traces from the same cell were averaged and
normalized for each graph.
Culture of Primary Hippocampal Neurons and
Immunocytochemistry
Primary hippocampal neuronal cell cultures were prepared
from 18.5 days post coitum mouse embryos as previously described
[41]. Pregnant mothers were sacrificed by an overdose of
isoflurane and embryos by decapitation approved by the Guide
for the Care and Use of Laboratory Animals of the Government of
Upper Bavaria (Germany) as well as by the Animal Care and Use
Committee of the Max Planck Institute of Psychiatry (Munich,
Germany). Dissociated neurons were grown in Neurobasal-A
medium supplemented with B27 Supplement (Invitrogen) and
GlutaMAXI (Invitrogen). Neurons were plated on coverslips
(Menzel) coated with 50 mg/ml poly-D-lysine (Sigma) and 5 mg/
ml laminin (Invitrogen). After 20 days in vitro, neurons were fixed
with 4% paraformaldehyde containing 4% sucrose. Immunohis-
tochemistry was carried out as described [42], using the following
antibodies: anti-SSTR1 (1:50; Novus Biologicals, NB120-2366),
anti-PSD-95 (1:500; Neuromab, 75-028), anti-rabbit conjugated to
Alexa-Fluor 594 (1:1000; Invitrogen, A11037) and anti-mouse
conjugated to Alexa-Fluor 488 (1:1000; Invitrogen, A11029). To
confirm the specificity of the antibodies used to detect SSTR1 and
PSD-95, immunohistochemistry was performed as above but
omitting the first antibody (Figure S2). Nuclei were counterstained
using DAPI. Immunocytochemical analysis was carried out by
laser-scanning confocal microscopy. Images were acquired simul-
taneously in two acquisition channels with the FLUOVIEW FV
1000 (version 2.0a) acquisition analyzer program. Images were
digitalized using Image J, Adobe Photoshop CS2, and Adobe
Illustrator CS2.
Supporting Information
Figure S1 Correlation between SPR and FP binding
data. Scatter plot of Ki values for GPCR C-tails binding to each of
the PSD-95 PDZ domains measured by FP versus Kd values for the
same interactions measured by SPR. The dashed line indicates a
perfect correlation between the data. The dotted line is a line fit
(Y=A+B6X) to log-transformed data and it shows that the SPR
data on average gives Kd values that are 2 times higher than the Ki
values found by FP.
(TIF)
Figure S2 Assessement of the specificity of antibodies
against mSSTR1 and PSD-95 in primary hippocampal
neurons. Mouse neurons cultivated for 20 days in vitro were
stained for mSSTR1 (red signal, left panel) and PSD-95 (green
signal, right panel) using only secondary antibodies. Nuclei of
primary neurons were counterstained with 49,6-diamidino-2-
phenylindole (DAPI). No nonspecific staining was detectable.
Scale bars = 10 mm.
(TIF)
Figure S3 Sequence alignment of PSD-95 PDZ1, PDZ2,
and PDZ3. Residues that are predicted to contact the ligand are
highlighted in gray [35,43]. Secondary structure elements are
indicated above the sequence [35], notice that helix aC is only
found in PDZ3. Identical residues are indicated with asterisks;
conserved and semi-conserved residues are indicated with colons
and dots, respectively.
(TIF)
Table S1 Sequences of C-terminal tail peptides used for
fluorescence polarization and surface plasmon resonance experi-
ments.
(PDF)
Table S2 Comparison of Ki values for reference protein
interactions with Ki and Kd values from the literature.
(PDF)
Table S3 GPCRs found not to interact with PSD-95 using
fluorescence polarization.
(PDF)
Table S4 Kd values for interactions with the PSD-95 PDZ
domains determined by surface plasmon resonance.
(PDF)
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